Brain and retinal ferroportin 1 dysregulation in polycythaemia mice

Brain Research

Volumn 1289, Issue , 2009, Pages 85-95

  Iacovelli, Jared ^a   Mlodnicka, Agnieska E ^b   Veldman, Peter ^a   Ying, Gui Shuang ^a   Dunaief, Joshua L ^a   Schumacher, Armin ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Baylor Family Medicine   (United States)

Author keywords

Brain; Ferroportin; Iron; Polycythaemia; Retina

Indexed keywords

CD71 ANTIGEN; FERROPORTIN 1; IRON;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN LEVEL; CONTROLLED STUDY; EMBRYO; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IRON BALANCE; IRON DEFICIENCY ANEMIA; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOTORECEPTOR; POLYCYTHEMIA; PRIORITY JOURNAL; RETINA DEGENERATION; RETINA DEVELOPMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGE FACTORS; ANIMALS; BLOTTING, WESTERN; BRAIN; BRAIN CHEMISTRY; CATION TRANSPORT PROTEINS; CELL COUNT; DOWN-REGULATION; FLUORESCENT ANTIBODY TECHNIQUE; HOMEOSTASIS; HOMOZYGOTE; IMMUNOHISTOCHEMISTRY; IRON; MICE; MICE, KNOCKOUT; MUTATION; PHOTORECEPTOR CELLS, VERTEBRATE; POLYCYTHEMIA; RETINA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

MAMMALIA; MUS;

EID: 68649097621     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.06.098     Document Type: Article

References (49)

1. Aisen P., Enns C., and Wessling-Resnick M. Chemistry and biology of eukaryotic iron metabolism. Int. J. Biochem. Cell. Biol. 33 (2001) 940-959
2. Ballabh P., Braun A., and Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis. 16 (2004) 1-13
3. Beard J. Iron deficiency alters brain development and functioning. J. Nutr. 133 (2003) 1468S-1472S
4. Beard J. Recent evidence from human and animal studies regarding iron status and infant development. J. Nutr. 137 (2007) 524S-530S
5. Beard J.L., and Connor J.R. Iron status and neural functioning. Annu. Rev. Nutr. 23 (2003) 41-58
6. Bernstein S.E. Hereditary hypotransferrinemia with hemosiderosis, a murine disorder resembling human atransferrinemia. J. Lab. Clin. Med. 110 (1987) 690-705
7. Bradbury M.W. Transport of iron in the blood-brain-cerebrospinal fluid system. J. Neurochem. 69 (1997) 443-454
8. Carraro M.C., Rossetti L., and Gerli G.C. Prevalence of retinopathy in patients with anemia or thrombocytopenia. Eur. J. Haematol. 67 (2001) 238-244
9. Cepko C.L., Austin C.P., Yang X., Alexiades M., and Ezzeddine D. Cell fate determination in the vertebrate retina. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 589-595
10. Curtis A.R., Fey C., Morris C.M., Bindoff L.A., Ince P.G., Chinnery P.F., Coulthard A., Jackson M.J., Jackson A.P., McHale D.P., Hay D., Barker W.A., Markham A.F., Bates D., Curtis A., and Burn J. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat. Genet. 28 (2001) 350-354
11. Danciger M., Lyon J., Worrill D., LaVail M.M., and Yang H. A strong and highly significant QTL on chromosome 6 that protects the mouse from age-related retinal degeneration. Invest. Ophthalmol. Vis. Sci. 44 (2003) 2442-2449
12. Danciger M., Yang H., Ralston R., Liu Y., Matthes M.T., Peirce J., and Lavail M.M. Quantitative genetics of age-related retinal degeneration: a second F1 intercross between the A/J and C57BL/6 strains. Mol. Vis. 13 (2007) 79-85
13. Dentchev T., Hahn P., and Dunaief J.L. Strong labeling for iron and the iron-handling proteins ferritin and ferroportin in the photoreceptor layer in age-related macular degeneration. Arch. Ophthalmol. 123 (2005) 1745-1746
14. Donovan A., Lima C.A., Pinkus J.L., Pinkus G.S., Zon L.I., Robine S., and Andrews N.C. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell. Metab. 1 (2005) 191-200
15. Dunaief J.L., King A., Esumi N., Eagen M., Dentchev T., Sung C.H., Chen S., and Zack D.J. Protein Phosphatase 1 binds strongly to the retinoblastoma protein but not to p107 or p130 in vitro and in vivo. Curr. Eye Res. 24 (2002) 392-396
16. Dunaief J.L., Richa C., Franks E.P., Schultze R.L., Aleman T.S., Schenck J.F., Zimmerman E.A., and Brooks D.G. Macular degeneration in a patient with aceruloplasminemia, a disease associated with retinal iron overload. Ophthalmology 112 (2005) 1062-1065
17. Felt B.T., and Lozoff B. Brain iron and behavior of rats are not normalized by treatment of iron deficiency anemia during early development. J. Nutr. 126 (1996) 693-701
18. Gresh J., Goletz P.W., Crouch R.K., and Rohrer B. Structure-function analysis of rods and cones in juvenile, adult, and aged C57bl/6 and Balb/c mice. Vis. Neurosci. 20 (2003) 211-220
19. Hadziahmetovic M., Dentchev T., Song Y., Haddad N., He X., Hahn P., Pratico D., Wen R., Harris Z.L., Lambris J.D., Beard J., and Dunaief J.L. Ceruloplasmin/hephaestin knockout mice model morphologic and molecular features of AMD. Invest. Ophthalmol. Vis. Sci. 49 (2008) 2728-2736
20. Hahn P., Milam A.H., and Dunaief J.L. Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane. Arch. Ophthalmol. 121 (2003) 1099-1105
21. Hahn P., Qian Y., Dentchev T., Chen L., Beard J., Harris Z.L., and Dunaief J.L. Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 13850-13855
22. Hentze M.W., Muckenthaler M.U., and Andrews N.C. Balancing acts: molecular control of mammalian iron metabolism. Cell 117 (2004) 285-297
23. He X., Hahn P., Iacovelli J., Wong R., King C., Bhisitkul R., Massaro-Giordano M., and Dunaief J.L. Iron homeostasis and toxicity in retinal degeneration. Prog. Retin. Eye Res. 26 (2007) 649-673
24. Holt J.M., and Gordon-Smith E.C. Retinal abnormalities in diseases of the blood. Br. J. Ophthalmol. 53 (1969) 145-160
25. Jeong S.Y., and David S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J. Biol. Chem. 278 (2003) 27144-27148
26. Jeong S.Y., and David S. Age-related changes in iron homeostasis and cell death in the cerebellum of ceruloplasmin-deficient mice. J. Neurosci. 26 (2006) 9810-9819
27. Kim S.Y., Levenson J.M., Korsmeyer S., Sweatt J.D., and Schumacher A. Developmental regulation of Eed complex composition governs a switch in global histone modification in brain. J. Biol. Chem. 282 (2007) 9962-9972
28. Kwik-Uribe C.L., Gietzen D., German J.B., Golub M.S., and Keen C.L. Chronic marginal iron intakes during early development in mice result in persistent changes in dopamine metabolism and myelin composition. J. Nutr. 130 (2000) 2821-2830
29. LaVaute T., Smith S., Cooperman S., Iwai K., Land W., Meyron-Holtz E., Drake S.K., Miller G., Abu-Asab M., Tsokos M., Switzer III R., Grinberg A., Love P., Tresser N., and Rouault T.A. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat. Genet. 27 (2001) 209-214
30. Lozoff B., and Georgieff M.K. Iron deficiency and brain development. Semin Pediatr. Neurol. 13 (2006) 158-165
31. Miyajima H., Nishimura Y., Mizoguchi K., Sakamoto M., Shimizu T., and Honda N. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 37 (1987) 761-767
32. Mok H., Jelinek J., Pai S., Cattanach B.M., Prchal J.T., Youssoufian H., and Schumacher A. Disruption of ferroportin 1 regulation causes dynamic alterations in iron homeostasis and erythropoiesis in polycythaemia mice. Development 131 (2004) 1859-1868
33. Mok H., Mendoza M., Prchal J.T., Balogh P., and Schumacher A. Dysregulation of ferroportin 1 interferes with spleen organogenesis in polycythaemia mice. Development 131 (2004) 4871-4881
34. Mok H., Mlodnicka A.E., Hentze M.W., Muckenthaler M., and Schumacher A. The molecular circuitry regulating the switch between iron deficiency and overload in mice. J. Biol. Chem. 281 (2006) 7946-7951
35. Moos T., and Morgan E.H. Transferrin and transferrin receptor function in brain barrier systems. Cell. Mol. Neurobiol. 20 (2000) 77-95
36. Morita H., Ikeda S., Yamamoto K., Morita S., Yoshida K., Nomoto S., Kato M., and Yanagisawa N. Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann. Neurol. 37 (1995) 646-656
37. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., Ganz T., and Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 (2004) 2090-2093
38. Pandolfo M. Friedreich's ataxia: clinical aspects and pathogenesis. Semin. Neurol. 19 (1999) 311-321
39. Patel B.N., Dunn R.J., Jeong S.Y., Zhu Q., Julien J.P., and David S. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J. Neurosci. 22 (2002) 6578-6586
40. Ponka P. Hereditary causes of disturbed iron homeostasis in the central nervous system. Ann. N.Y. Acad. Sci. 1012 (2004) 267-281
41. Rouault T.A. Systemic iron metabolism: a review and implications for brain iron metabolism. Pediatr. Neurol. 25 (2001) 130-137
42. Taneja V., Mishra K., and Agarwal K.N. Effect of early iron deficiency in rat on the gamma-aminobutyric acid shunt in brain. J. Neurochem. 46 (1986) 1670-1674
43. Taylor E.M., Crowe A., and Morgan E.H. Transferrin and iron uptake by the brain: effects of altered iron status. J. Neurochem. 57 (1991) 1584-1592
44. Trenor III C.C., Campagna D.R., Sellers V.M., Andrews N.C., and Fleming M.D. The molecular defect in hypotransferrinemic mice. Blood 96 (2000) 1113-1118
45. Wu L.J., Leenders A.G., Cooperman S., Meyron-Holtz E., Smith S., Land W., Tsai R.Y., Berger U.V., Sheng Z.H., and Rouault T.A. Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier. Brain Res. 1001 (2004) 108-117
46. Xu X., Pin S., Gathinji M., Fuchs R., and Harris Z.L. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Ann. N.Y. Acad. Sci. 1012 (2004) 299-305
47. Yamaguchi K., Takahashi S., Kawanami T., Kato T., and Sasaki H. Retinal degeneration in hereditary ceruloplasmin deficiency. Ophthalmologica 212 (1998) 11-14
48. Yehuda S., and Youdim M.B. Brain iron: a lesson from animal models. Am. J. Clin. Nutr. 50 (1989) 618-625 discussion 625-9
49. Zhou B., Westaway S.K., Levinson B., Johnson M.A., Gitschier J., and Hayflick S.J. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat. Genet. 28 (2001) 345-349